U.S. Physical Therapy Inc (USPH) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 2, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
41
Open-market buys
5
Open-market sells
14
Buys, 10b5-1 box not checked
5 of 5

Counts cover the 41 most recent Form 4 filings Tradune holds for USPH (filed May 21 – Oct 2, 2026); the score below covers only the trailing 90 days (1 buy, 0 sells). No completed check of USPH's Form 4 list on SEC EDGAR is on record yet; the latest USPH filing Tradune holds was filed Oct 2, 2026. This is not guaranteed to be the complete record — see USPH's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 7 filings Tradune holds for USPH filed Aug 24 – Oct 2, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Peter Francis MinanDirector 2 0 6 — +$474

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
56/ 100
Net insider purchases
1 distinct buyer1 buy · 0 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at USPH

Insiders reported 5 open-market purchases of USPH between May 21, 2025 and Oct 2, 2026, across 2 distinct buyers. The most recent purchase was reported by Peter Francis Minan (Director) on Sep 11, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Myra Davis Director · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 1,210 — 1,210 — Oct 1, 2026
Nchacha Etta EVP & Chief Financial Officer · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 6,831 — 6,831 — Sep 14, 2026
Peter Francis Minan Director · filed Sep 14, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 5 $79.00 3,217 +0.2% Sep 11, 2026
Open-market purchase 10b5-1 box not checked 1 $66.50 3,212 +0.0% Jun 12, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Eric Joseph Williams President and COO · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 714 $78.00 39,617 −1.8% Aug 20, 2026
Jason Travis Curtis Interim CFO · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 40 $78.00 3,853 −1.0% Aug 20, 2026
Richard Binstein EVP Gen'l Counsel & Secretary · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 450 $78.00 24,417 −1.8% Aug 20, 2026
Graham D. Reeve COO · filed Aug 24, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 762 $78.00 28,554 −2.6% Aug 20, 2026
Jason Travis Curtis Interim CFO · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 40 $62.24 3,893 −1.0% May 20, 2026
Graham D. Reeve COO · filed Jun 22, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 762 $62.24 29,316 −2.5% May 20, 2026
Peter Francis Minan Director · filed Jun 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 288 $61.50 3,211 +9.9% Jun 9, 2026
Open-market purchase 10b5-1 box not checked 492 $63.14 2,923 +20% Jun 8, 2026
Anne Motsenbocker Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 2,306 $61.61 9,812 +31% May 19, 2026
Regg E. Swanson Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 2,306 $61.61 15,492 +17% May 19, 2026
Peter Francis Minan Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 2,306 $61.61 2,431 +1,845% May 19, 2026
Bernard A. Harris Jr. Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 2,306 $61.61 20,914 +12% May 19, 2026
Kathleen A. Gilmartin Director · filed May 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 2,306 $61.61 27,092 +9.3% May 19, 2026
Graham D. Reeve COO · filed Mar 12, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 662 $78.86 30,078 −2.2% Mar 11, 2026
Graham D. Reeve COO · filed Mar 11, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1 $78.52 0 (indirect) from 1 sh Mar 9, 2026
Open-market sale 10b5-1 box not checked 1,807 $82.25 1 (indirect) −100% Mar 6, 2026
Carey P. Hendrickson Chief Financial Officer · filed Mar 10, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Disposition to issuer 10,000 — 27,808 −26% Mar 9, 2026
Richard Binstein EVP Gen'l Counsel & Secretary · filed Mar 9, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 3,000 $81.64 24,867 −11% Mar 6, 2026
Christopher J. Reading Chairman of the Board and CEO · filed Feb 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 25,000 — 139,088 +22% Feb 23, 2026
Eric Joseph Williams President and COO · filed Feb 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 15,000 — 40,331 +59% Feb 23, 2026
Graham D. Reeve COO · filed Feb 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 10,000 — 30,740 +48% Feb 23, 2026
Richard Binstein EVP Gen'l Counsel & Secretary · filed Feb 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 10,000 — 27,867 +56% Feb 23, 2026
Carey P. Hendrickson Chief Financial Officer · filed Feb 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 10,000 — 37,808 +36% Feb 23, 2026
Graham D. Reeve COO · filed Nov 25, 2025 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 743 $71.01 20,740 −3.5% Nov 24, 2025

Listing the 25 most recent of 41 Form 4 filings held for USPH; the 16 older filings (filed May 21 – Nov 24, 2025) are counted above but not listed here — see USPH's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to USPH's (Oct 2, 2026).

Frequently asked about USPH insider activity

How many insiders bought USPH stock in these Form 4 filings?

2 distinct insiders at U.S. Physical Therapy Inc reported 5 open-market purchases (Form 4 code P) of USPH shares between May 21, 2025 and Oct 2, 2026, the most recent filed by Peter Francis Minan (Director) on Sep 11, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for USPH?

The most recent Form 4 on this page was filed by Myra Davis (Director) on Oct 2, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market USPH insider purchase shown?

The largest open-market purchase among the filings shown was 4,000 USPH shares at $69.00 (about $276,000) by Kathleen A. Gilmartin (Director) on Nov 20, 2025. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent USPH insider purchases have the Form 4 10b5-1 box checked?

No. All 5 USPH open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Peter Francis Minan (Director) on Sep 11, 2026, 5 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for USPH — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track USPH insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.